NZ$28.86
2.00%
New Zealand Exchange, Tue, Nov 18 2025
ISIN
NZEBOE0001S6
Symbol
EBO

Ebos Group Stock price

NZ$28.86
+0.22 0.77% 1M
-10.02 25.77% 6M
-8.14 21.99% YTD
-7.72 21.10% 1Y
-11.66 28.78% 3Y
+3.82 15.27% 5Y
+14.91 106.88% 10Y
+25.49 755.59% 20Y
New Zealand Exchange, Closing price Tue, Nov 18 2025
-0.59 2.00%
ISIN
NZEBOE0001S6
Symbol
EBO

Key metrics

Basic
Market capitalization
NZ$5.9b
Enterprise Value
NZ$7.6b
Net debt
NZ$1.7b
Cash
NZ$211.9m
Shares outstanding
203.2m
Valuation (TTM | estimate)
P/E
23.6 | 19.2
P/S
0.4 | 0.4
EV/Sales
0.5 | 0.5
EV/FCF
24.2
P/B
1.9
Dividends
DPS
NZ$1.35
Yield 1Y | 5Y
4.4% | 3.1%
Growth 1Y | 5Y
4.1% | 9.9%
Payout 1Y | 3Y
108.1% | 86.6%
Increased
5 Years
Financials (TTM | estimate)
Revenue
NZ$14.1b | NZ$15.3b
EBITDA
NZ$654.2m | NZ$732.2m
EBIT
NZ$485.6m | NZ$570.7m
Net Income
NZ$246.9m | NZ$311.8m
Free Cash Flow
NZ$312.8m
Growth (TTM | estimate)
Revenue
-7.0% | 8.6%
EBITDA
-6.8% | 11.9%
EBIT
-12.3% | 17.5%
Net Income
-20.8% | 26.3%
Free Cash Flow
18.8%
Margin (TTM | estimate)
Gross
13.4%
EBITDA
4.7% | 4.8%
EBIT
3.5%
Net
1.8% | 2.0%
Free Cash Flow
2.2%
Financial Health
Equity Ratio
37.6%
Return on Equity
7.9%
ROCE
9.1%
ROIC
6.5%
Debt/Equity
0.6
More
EPS
NZ$1.3
FCF per Share
NZ$1.5
Short interest
-
Employees
-
Rev per Employee
-
Show more

Is Ebos Group a Top Scorer Stock based on the Dividend, High-Growth-Investing or Leverman Strategy?

As a Free StocksGuide user, you can view scores for all 7,042 stocks worldwide.

Ebos Group Stock Analysis

Unlock Scores for Free

Analyst Opinions

13 Analysts have issued a Ebos Group forecast:

10x Buy
77%
3x Hold
23%

Analyst Opinions

13 Analysts have issued a Ebos Group forecast:

Buy
77%
Hold
23%

Financial data from Ebos Group

Income Statement P&L | Balance Sheet | Cash Flow


Quarter TTM Annually
Jun '25
+/-
%
14,080 14,080
7% 7%
100%
- Direct Costs 12,201 12,201
8% 8%
87%
1,879 1,879
0% 0%
13%
- Selling and Administrative Expenses 674 674
3% 3%
5%
- Research and Development Expense - -
-
-
654 654
7% 7%
5%
- Depreciation and Amortization 169 169
14% 14%
1%
EBIT (Operating Income) EBIT 486 486
12% 12%
3%
Net Profit 247 247
21% 21%
2%

In millions NZD.

Don't miss a Thing! We will send you all news about Ebos Group directly to your mailbox free of charge.

If you wish, we will send you an e-mail every morning with news on stocks of your portfolios.

Company Profile

EBOS Group Ltd. engages in the provision of healthcare and animal care products and services. The firm is a marketer and distributor of animal care brands. Its segments include Healthcare, Animal Care, and Corporate. The Healthcare segment includes sales of healthcare products in a range of sectors, own brands, retail healthcare, pharmacy, hospital and logistic services, and wholesale activities. The Animal Care segment includes sales of animal care products in a range of sectors, own manufactured and contract manufactured brands, retail, and wholesale activities. The company sources and supplies a range of surgical, medical, and pharmaceutical products. Its Community Pharmacy business includes Symbion, ProPharma, Pharmacy Wholesalers Russells, TerryWhite Chemmart, Good Price Pharmacy Warehouse, healthSAVE, Ventura Health, Minfos, DoseAid, Intellipharm, Endeavour Consumer Health, and Red Seal. Its contract logistics include Healthcare Logistics and Clinect.

Head office Australia
CEO Mr. Cullity
Website www.ebosgroup.com

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

The Apple stock at a glance with charts, current key metrics, news and stock analyses.
The Best Dividend Stocks in the Dividend Top Scorer list.
Stock Analyses of the Best Stocks Worldwide.
Start building wealth today